Search results
Bayer investor Deka takes a stand against CEO in annual vote
Reuters via Yahoo News· 1 hour agoFRANKFURT (Reuters) -Bayer shareholder Deka Investment said on Friday it would not join other large...
Merck Stock Gains On Its Blockbuster Cancer Drug Keytruda, Raises Annual Outlook
Benzinga via Yahoo Finance· 16 hours agoOn Thursday, U.S. drug maker Merck & Co Inc (NYSE:MRK) reported first-quarter sales of $15.8...
Cancer drugs help drive AstraZeneca sales sharply higher
PA Media: Money via Yahoo Finance· 22 hours agoPascal Soriot, chief executive of the company, said it “had a very strong start in 2024”. It...
USDA tells producers to reduce salmonella in certain frozen chicken products
KY3 Springfield· 23 minutes agoWhen the regulation takes effect in 2025, salmonella will be considered an adulterant — a...
Merck Stock Climbs After Higher-Than-Expected Sales of Cancer Drug Keytruda
The Wall Street Journal· 21 hours agoShares of U.S. drugmaker Merck are up nearly 4% in recent trading after the company said its...
Merck highlights progress on HIV, hypertension, cervical cancer drugs
WFMZ Eastern Pennsylvania and Western New Jersey· 17 hours agoMerck, with multiple facilities in eastern Pennsylvania and New Jersey, also delivered good news...
New tool offers potential breakthrough to hold companies accountable for deforestation: 'We need to...
The Cool Down via Yahoo News· 7 hours agoBottrill began the 2000s working in Vietnam before transitioning to the World Wildlife Fund. After a...
Q1 2025 Earnings Forecast for Albertsons Companies, Inc. (NYSE:ACI) Issued By Telsey Advisory Group
ETF DAILY NEWS· 7 hours agoTelsey Advisory Group analyst J. Feldman now anticipates that the company will post earnings of...
Merck raises 2024 profit forecast on strong cancer, HPV drugs sales
WSAU Wausau· 22 hours agoBy Patrick Wingrove (Reuters) - Merck & Co on Thursday raised its annual profit and revenue forecast...
Xaira Therapeutics $1 billion funding round shows the excitement about AI drug discovery
Fortune· 19 hours agoThe pursuit to use AI to discover new life-saving drugs got a big boost this week when a new company, Xaira Therapeutics, emerged from stealth with $1 billion in funding.